Wolters Kluwer Opioid Toolkit Supports Patients at Every Step in the Care Journey

New toolkit addresses clinical variability in pain therapy to help
clinicians stem the opioid crisis

WALTHAM, Mass.–(BUSINESS WIRE)–lt;a href=”https://twitter.com/hashtag/Opiods?src=hash” target=”_blank”gt;#Opiodslt;/agt;–With over
130 people dying from opioid overdoses every day
, health systems
around the United States are implementing cross-functional opioid task
force teams to reduce overdoses, treat dependence and addiction, and
prevent iatrogenic opioid use disorder that may start while patients are
receiving care.¹ To help our customers comply with the latest
regulations, Wolters
Kluwer, Health
is launching a comprehensive toolkit for opioid
taskforces in healthcare systems and pharmacy chains to address clinical
variability in opioid-related pain therapy care and stem the tide of the
opioid epidemic.

“Our approach to the opioid crisis targets not only patient behaviors
but also care team behaviors,” said Priti Shah, Vice President, Products
and Solutions, Clinical Effectiveness, at Wolters Kluwer, Health. “We
need to address clinical variability at each touch point with the
patient—physicians, nurses, and pharmacists—while also promoting safer
opioid use among patient populations. To achieve that, care teams must
be aligned in their decisions to ensure consistent care delivery across
the pain therapy journey. ”

The Wolters Kluwer Opioid Toolkit equips care teams and opioid
task forces with solutions that span the care continuum:

At Hospitals, Clinics and Community Health Centers:

  • Whether during a consultation or hospital stay, patients often start
    their pain therapy journey with a nurse, physician or other clinician. UpToDate®
    evidence-based content
    helps clinicians in assessing if
    opioids are appropriate. In 2018 alone, UpToDate topics related to
    opioids and pain management were consulted by clinicians over 4.5
    million times.
  • A new UpToDate® Pathway helps clinicians calculate a Morphine
    Milligram Equivalent (MME) (and independently review the basis of such
    calculation) for oral opioids and transdermal fentanyl. In addition,
    the UpToDate® Pathway assists clinicians in using the MME as one
    factor when assessing a patient’s risk for a potential opioid overdose
    and need for additional monitoring and safeguards (e.g.,
    naloxone).

At Retail or Hospital Pharmacies:

  • When a clinician determines opioids are warranted, a patient’s next
    step in the pain therapy journey is at the pharmacy, either at a
    hospital or within the patient’s community. Pharmacists preparing
    prescriptions consult Lexicomp®
    to check for opioid medication dosing.
  • The new Medi-Span® CNS Depressant Interactions data helps
    prescribers and pharmacists check for high-risk opioid interactions
    that could affect the central nervous system, including the dangerous
    combination of opioids, benzodiazepines, and central muscle relaxants.
    With additional Medi-Span drug data integrated within the pharmacy
    management system, pharmacists may also screen the script for MME
    calculations, State and Federal DEA codes, and potential precautions
    or contraindications with warning labels.

At Home:

  • A consistent, supportive dialogue with care teams about safe opioid
    use must be part of the patient’s pain therapy journey. Back at home
    however, a patient may feel vulnerable without the support of care
    professionals nearby. To extend the reach of that support, the Emmi®
    Opioid Appropriate Use solution
    helps educate patients with
    interactive programs that guide them along a healthy path for pain
    management. In surveys, patients said that Emmi opioid multimedia
    programs helped them be more informed, discover unknown risks, and
    make better decisions, thus empowering them to engage in healthier
    behaviors that enable them to resume activities of daily living.

KLAS Recommends a Multifaceted, Toolkit Approach

In a recent KLAS study, How
are Providers Tackling the Opioid Epidemic?
, only seven
out of 112 providers surveyed characterized their efforts to foster
appropriate and safe usage as “advanced,” with multiple technologies and
strategies, in place. The KLAS survey concluded “Advanced organizations
report that a multifaceted approach – consisting of internal rules,
technology partners, alternative treatment options, electronic
prescriptions for controlled substances, and proper legislation – is
necessary for effective opioid stewardship. Organizations that take such
an approach have realized gains in their fight against opioid misuse.”2

Enhancing Medication Management of Opioids with Real-Time Surveillance

The Wolters Kluwer Opioid Toolkit is complemented by Sentri7®
which provides hospital systems with real-time clinical surveillance
technology for the inpatient setting to help hospitals monitor and
prevent adverse drug events related to opioid use.

To learn more about the Opioid Toolkit solution, please visit https://go.wolterskluwer.com/Opioid-Toolkit.html.

¹ National Institute on Drug Abuse, ‘Opioid Overdose Crisis’, National
Institute on Drug Abuse
, [Website], https://www.drugabuse.gov/drugs-abuse/opioids/opioid-overdose-crisis,
(accessed May 2, 2019).

2 KLAS Research, ‘Opioid Management Perception 2018: EMR
Vendors Being Pushed to Center Stage’, KLAS Research, [Website], https://klasresearch.com/report/opioid-management-perception-2018/1346,
(accessed May 2, 2019).

About Wolters Kluwer

Wolters Kluwer N.V. (AEX: WKL) is a global provider of professional
information, software solutions, and services for physicians, nurses,
accountants, lawyers, tax specialists, and finance, audit, compliance,
and regulatory sectors.

The company provides expert solutions – a combination of deep domain
knowledge with specialized technology and services – that help
professionals navigate change, solve complex problems, and deliver
impact in their respective fields.

Headquartered in Alphen aan den Rijn, the Netherlands, Wolters Kluwer
holds market-leading positions in 40 countries globally, represents
customers across 180 countries and employs 18,600 people worldwide. In
2018, it reported annual revenues of €4.3 billion.

Wolters Kluwer provides trusted clinical technology and evidence-based
solutions that engage clinicians, patients, researchers and students
with advanced clinical decision support, learning and research and
clinical intelligence. For more information about our solutions, visit http://healthclarity.wolterskluwer.com and
follow us on LinkedIn and
Twitter @WKHealth.

For more information, visit www.wolterskluwer.com,
follow us on TwitterFacebookLinkedIn,
and YouTube.

Contacts

André Rebelo
Public Relations Manager
Wolters Kluwer Health
+1
781.392.2411
[email protected]

error: Content is protected !!